Danforth Advisors

No. Danforth is a financial and operational services firm, not an investment fund. It sells outsourced CFO, accounting, and strategic finance capacity to life-sciences companies. The firm does not take equity positions or co-invest alongside its clients.

The firm works exclusively with life-sciences and healthcare companies, from pre-revenue biotech startups to public commercial-stage pharmaceutical and medical-device firms. Its model is built for companies that need senior finance leadership but cannot yet justify a full-time CFO.

Danforth embeds its managing directors and controllers inside client organizations on a fractional, ongoing basis. Consultants typically deliver project-based recommendations and exit. Danforth practitioners function as the client's actual CFO or controller — running board meetings, managing audits, and leading capital raises — often for years.

Danforth operates as a private partnership. It was co-founded in 2011 by managing director Gregg Beloff and has grown by bringing on additional managing directors, each with their own life-sciences finance track record. It has not disclosed outside capital raises or corporate ownership.

Danforth is headquartered in Waltham, Massachusetts, within the Boston-Cambridge life-sciences cluster. The firm's client base is concentrated in the northeastern US, though it serves companies across the United States, reflecting the distributed geography of biotech innovation.